3,5,5-三甲基恶唑烷-2,4-二酮
|
T337770-5g
|
Moligand™, ≥98% |
127-48-0 |
5g
|
¥ 1122.9
|
现货 |
阿拉丁 |
4-(2-吡啶基)苯甲醛
|
P160242-100g
|
≥95% |
127406-56-8 |
100g
|
¥ 682.9
|
现货 |
阿拉丁 |
羟甲基二茂铁
|
H157111-50g
|
≥95% |
1273-86-5 |
50g
|
¥ 1729.9
|
现货 |
阿拉丁 |
氟氢可的松
|
F340821-5mg
|
Moligand™, ≥97% |
127-31-1 |
5mg
|
¥ 514.9
|
现货 |
阿拉丁 |
氟氢可的松
|
F340821-25mg
|
Moligand™, ≥97% |
127-31-1 |
25mg
|
¥ 1850.9
|
现货 |
阿拉丁 |
羟基脲
|
H106352-500g
|
Moligand™, ≥98% |
127-07-1 |
500g
|
¥ 453.9
|
现货 |
阿拉丁 |
(4-苄基哌嗪-1-基)(2-(异戊基氨基)吡啶-3-基)甲酮
|
B180959-5g
|
≥98% |
1270138-40-3 |
5g
|
¥ 778.9
|
现货 |
阿拉丁 |
APX-115自由基
|
A412540-50mg
|
Moligand™, ≥99% |
1270084-92-8 |
50mg
|
¥ 591.9
|
现货 |
阿拉丁 |
APX-115自由基
|
A412540-10mg
|
Moligand™, ≥99% |
1270084-92-8 |
10mg
|
¥ 251.9
|
现货 |
阿拉丁 |
2-氟-4-(三氟甲基)苯甲酰氯
|
F166821-250mg
|
≥98% |
126917-10-0 |
250mg
|
¥ 128.9
|
现货 |
阿拉丁 |
BioE-1115
|
B412674-50mg
|
≥98% |
1268863-35-9 |
50mg
|
¥ 646.9
|
现货 |
阿拉丁 |
BioE-1115
|
B412674-10mg
|
≥98% |
1268863-35-9 |
10mg
|
¥ 326.9
|
现货 |
阿拉丁 |
BioE-1115
|
B412674-100mg
|
≥98% |
1268863-35-9 |
100mg
|
¥ 1098.9
|
现货 |
阿拉丁 |
LDN 193188,磷脂酰胆碱转移蛋白(PC-TP)抑制剂
|
L287465-5mg
|
≥99%(HPLC) |
1267610-30-9 |
5mg
|
¥ 885.9
|
现货 |
阿拉丁 |
LDN 193188,磷脂酰胆碱转移蛋白(PC-TP)抑制剂
|
L287465-25mg
|
≥99%(HPLC) |
1267610-30-9 |
25mg
|
¥ 2616.9
|
现货 |
阿拉丁 |
LDN 193188,磷脂酰胆碱转移蛋白(PC-TP)抑制剂
|
L287465-100mg
|
≥99%(HPLC) |
1267610-30-9 |
100mg
|
¥ 6694.9
|
现货 |
阿拉丁 |
地拉罗司甲酯
|
D334631-50mg
|
≥98% |
1266741-05-2 |
50mg
|
¥ 865.9
|
现货 |
阿拉丁 |
地拉罗司甲酯
|
D334631-250mg
|
≥98% |
1266741-05-2 |
250mg
|
¥ 2574.9
|
现货 |
阿拉丁 |
GS967
|
G413260-25mg
|
Moligand™, ≥99% |
1262618-39-2 |
25mg
|
¥ 1324.9
|
现货 |
阿拉丁 |
GS967
|
G413260-100mg
|
Moligand™, ≥99% |
1262618-39-2 |
100mg
|
¥ 3706.9
|
现货 |
阿拉丁 |
NMS-P118
|
N413987-250mg
|
≥97% |
1262417-51-5 |
250mg
|
¥ 15757.9
|
现货 |
阿拉丁 |
NMS-P118
|
N413987-100mg
|
≥97% |
1262417-51-5 |
100mg
|
¥ 10195.9
|
现货 |
阿拉丁 |
GS-444217
|
G412159-50mg
|
Moligand™, ≥98% |
1262041-49-5 |
50mg
|
¥ 1335.9
|
现货 |
阿拉丁 |
GS-444217
|
G412159-10mg
|
Moligand™, ≥98% |
1262041-49-5 |
10mg
|
¥ 624.9
|
现货 |
阿拉丁 |